Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -21,500 | -23,400 | -19,700 | 6,900 | -11,700 |
| Other Working Capital | -60,200 | -27,800 | -36,000 | -8,700 | -19,500 |
| Other Operating Activity | 145,300 | 174,100 | 144,800 | 108,200 | 113,000 |
| Operating Cash Flow | $63,600 | $122,900 | $89,100 | $106,400 | $81,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22,600 | -20,300 | -18,700 | -7,600 | -11,700 |
| Net Acquisitions | -396,900 | -800 | -1,700 | -32,800 | -39,700 |
| Purchase Sale Intangibles | -5,500 | -56,100 | -114,400 | -40,100 | -9,500 |
| Other Investing Activity | -1,200 | -1,100 | -1,100 | -1,000 | -1,000 |
| Investing Cash Flow | $-426,200 | $-78,300 | $-136,100 | $-81,500 | $-61,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 357,400 | N/A | 0 | 297,300 | 44,100 |
| Debt Repayment | -166,800 | 0 | -15,900 | -271,700 | -36,800 |
| Common Stock Issued | 181,900 | 2,300 | 2,300 | 131,500 | 1,200 |
| Dividend Paid | -51,700 | -44,800 | -37,900 | -33,300 | -28,400 |
| Other Financing Activity | -4,300 | -3,600 | -3,600 | -4,900 | -200 |
| Financing Cash Flow | $316,500 | $-46,100 | $-55,100 | $118,900 | $-20,100 |
| Exchange Rate Effect | -400 | 4,000 | -6,900 | 3,300 | 800 |
| Beginning Cash Position | 120,900 | 118,400 | 227,400 | 80,300 | 79,700 |
| End Cash Position | 74,400 | 120,900 | 118,400 | 227,400 | 80,300 |
| Net Cash Flow | $-46,100 | $-1,500 | $-102,100 | $143,800 | $-200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 63,600 | 122,900 | 89,100 | 106,400 | 81,800 |
| Capital Expenditure | -30,300 | -77,600 | -134,800 | -49,200 | -22,500 |
| Free Cash Flow | 33,300 | 45,300 | -45,700 | 57,200 | 59,300 |